Weekly News Wire | May 25, 2009
Two Drug Makers Stand Behind Products in Pay-for Performance Deals With Insurers
OPEN MINDS Weekly News Wire Strategic Health Care News In April 2009, two pharmaceutical manufacturers, Merck and Procter & Gamble/Sanofi-Aventis, agreed to deals with insurers to adjust their charges for select medications based on the medicationÂ’s performance. Merck agreed to link what CIGNA pays for oral anti-diabetes drugs Januvia and Janumet to how well patients with Type 2 diabetes are able to control their blood sugar regardless of what diabetes medications they are taking. Blood sugar control will be measured, based on AC1 lab values, which reveal average blood glucose control over a period of time . . .
Want To Read More? Log In Or Become A Paid Member
